Cart
sales@molnova.com
4-O-Methyllucenin II (Diosmetin 6,8-di-C-glucoside)
CAS No. 98813-28-6
4-O-Methyllucenin II (Diosmetin 6,8-di-C-glucoside)( —— )
Catalog No. M32284 CAS No. 98813-28-6
Diosmetin 6,8-di-C-glucoside has antioxidant and anti-aging activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-O-Methyllucenin II (Diosmetin 6,8-di-C-glucoside)
-
NoteResearch use only, not for human use.
-
Brief DescriptionDiosmetin 6,8-di-C-glucoside has antioxidant and anti-aging activities.
-
DescriptionDiosmetin 6,8-di-C-glucoside has antioxidant and anti-aging activities.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number98813-28-6
-
Formula Weight624.6
-
Molecular FormulaC28H32O16
-
Purity>98% (HPLC)
-
SolubilityDMSO, Pyridine, Methanol, Ethanol, etc.
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Egg yolk phosphatidy...
Lecithins, egg can be used as an excipient. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs.
-
[Trp7,β-Ala8]-Neurok...
[Trp7,β-Ala8]-Neurokinin A (4-10)
-
MRK-740
MRK-740 is a potent and selective inhibitor of PRDM9 histone methyltransferase.MRK-740 inhibits other histone methyltransferases and inhibits PRDM9-dependent H3K4 trimethylation.
